ClinicalTrials.Veeva

Menu

Effect of Drinking Fermented Milk on Immune Response

M

Mahidol University

Status

Completed

Conditions

Influenza

Treatments

Dietary Supplement: Drinking fermented milk
Dietary Supplement: placebo
Biological: Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)

Study type

Interventional

Funder types

Other

Identifiers

NCT02909842
MU-CIRB 2015/145.2509

Details and patient eligibility

About

This blinded randomized controlled trial aims to investigate the effect of drinking fermented milk containing Lactobacillus paracasei (IMULUS) on immune response against influenza.

Full description

This study is conducted in healthy volunteer using product approved by Thai FDA. This blinded randomized controlled trial compare immune response against influenza H1N1, H3N2 and Phu-B between study group and control group. The study group receives influenza vaccine and drinking fermented milk containing Lactobacillus paracasei (IMULUS), while the control group receives influenza vaccine and placebo acidified milk. The trial lasts for 8 weeks and include four time points of data collection (0, 2, 6, 8 weeks). Subjects, outcome assessor and investigators are blinded throughout the study.

Enrollment

60 patients

Sex

All

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18 45 years old
  • healthy and having normal vital signs
  • no history of uncontrolled systemic or autoimmune diseases
  • no signs or symptoms of respiratory infection
  • normal blood chemistry including complete blood count (CBC), liver and kidney function, lipid profile and fasting blood sugar
  • no history of influenza vaccine during the past 6 months
  • able to continuously take the intervention daily for 6 weeks
  • able to refrain from other probiotic products such as drinking fermented milk or yoghurt since the beginning till the end of data collection
  • accepted to receive influenza vaccine shot
  • able to refrain from receiving other vaccine during the trial
  • able to refrain from traveling to endemic area of influenza
  • able to communicate in Thai and sign their written inform consent

Exclusion criteria

  • under pregnancy or expected to be pregnant
  • lactose or milk protein intolerances
  • daily intake of probiotic product for one month prior to recruitment
  • chronic alcoholism
  • GI disturbance e.g. stomachache, frequent diarrhea or constipation
  • history of GI surgery
  • ongoing treatment with antibiotic or other immune affecting drugs e.g. glucocorticoids, chemotherapy, antibodies, ciclosporin, hormone and opioids

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

study group
Experimental group
Description:
Seasonal Influenza Vaccine (H1N1, H3N2, PhuB) and 100 ml bottle of yoghurt drink, unlabelled drinking fermented milk containing probiotic, Lactobacillus paracasei (IMULUS)
Treatment:
Dietary Supplement: Drinking fermented milk
Biological: Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)
control group
Placebo Comparator group
Description:
Seasonal Influenza Vaccine (H1N1, H3N2, PhuB) and 100 ml bottle of placebo, unlabelled acidified milk with similar physical and sensory appearance to the experimental one
Treatment:
Biological: Seasonal Influenza Vaccine (H1N1, H3N2, PhuB)
Dietary Supplement: placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems